Main Sequence Revenue and Competitors
Employee Data
- Main Sequence has 30 Employees.
- Main Sequence grew their employee count by 36% last year.
Main Sequence's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Operations - CSIRO Innovation Fund, Main Sequence Ventures | Reveal Email/Phone |
2 | Investment Manager | Reveal Email/Phone |
3 | Partner | Reveal Email/Phone |
4 | Legal Counsel and Company Secretary | Reveal Email/Phone |
5 | Partner | Reveal Email/Phone |
6 | Investment Associate | Reveal Email/Phone |
7 | Legal Counsel | Reveal Email/Phone |
8 | Partner | Reveal Email/Phone |
9 | Analyst | Reveal Email/Phone |
Main Sequence Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | N/A | 29 | 32% | N/A | N/A |
#2 | N/A | 30 | 36% | N/A | N/A |
#3 | N/A | 42 | 56% | N/A | N/A |
What Is Main Sequence?
We are Australia’s deep tech investment fund tackling the world’s biggest challenges by turning today’s scientific discoveries into tomorrow’s industries. \n\nMain Sequence works closely with scientists, researchers and industry collaborators to create, fund and accelerate new companies and industries that accelerate humanity for a more prosperous future. \n\nMain Sequence was set up in 2017 to manage the CSIRO Innovation Fund, founded by the Australian Government and the national science agency to reinvest its historic contributions into the successes of the future. \n\nOver the past four years, Main Sequence has invested in 39 companies changing the way healthcare is delivered, food is produced, spaces are connected and more. These investments have led to more than 60 company collaborative projects with universities and 19 projects with CSIRO.
keywords:N/A
N/A
Total Funding
30
Number of Employees
N/A
Revenue (est)
36%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Eveleigh
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.2M | 57 | -10% | N/A |
#2 | $9.4M | 72 | 6% | N/A |
#3 | $3.5M | 96 | N/A | N/A |
#4 | $21.2M | 137 | -4% | $33.8M |
#5 | $72.7M | 401 | 2% | N/A |